Cardiologia

Cuidados de fim de vida na UTI cardíaca: uma visão contemporânea do Critical Care Cardiology Trials Network (CCCTN) Registry.

31 Mar, 2022 | 13:06h

End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) Registry – European Heart Journal. Acute Cardiovascular Care

 

Comentário no Twitter

#EHJACVC Editors Choice:
End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) Registry

Big thank you to the @TIMIStudyGroup #CCCTN group for this important analysis! https://t.co/QJaPoTurLc pic.twitter.com/leOZRBNGTB

— EHJACVC Editor-in-Chief (@EHJACVCEiC) March 29, 2022

 

---

Estudo de coorte | Variações socioeconômicas determinam a apresentação clínica, a etiologia e o desfecho da endocardite infecciosa.

31 Mar, 2022 | 12:56h

Socio-Economic Variations Determine the Clinical Presentation, Aetiology and Outcome of Infective Endocarditis: a Prospective Cohort Study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) Registry – European Heart Journal – Quality of Care and Clinical Outcomes

 

Comentário no Twitter

Infective #endocarditis – do socio-economic factors impact presentation and prognosis? Unfortunately yes, according to data from EURO-ENDO Registry: https://t.co/JdKM5igihR #CVD #EHJQCCO @cpgale3 @diogoasantosfer pic.twitter.com/pkclJdRsdU

— European Society of Cardiology Journals (@ESC_Journals) March 28, 2022

 

---

Estudo randomizado por cluster | Uma intervenção domiciliar de substituição do sal é custo-efetiva para a prevenção de AVC e melhorar a qualidade de vida.

29 Mar, 2022 | 15:17h

Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS) – Circulation

Comentário: ACC: Use of Salt Substitute to Prevent Stroke Is Cost-Saving – HealthDay

Estudo original: #ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.

Conteúdos relacionados:

Former CDC director: Low sodium salt could save millions of lives – CNN

Is salt good for you after all? The evidence says no.

Systematic Review: Altered dietary salt intake for people with chronic kidney disease.

New WHO benchmarks help countries reduce salt intake and save lives.

RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels

Cluster Randomized Trial: Effect of Salt Substitution on Community-wide Blood Pressure and Hypertension Incidence

---

Estudo de coorte | Doença cardíaca e da artéria coronária são comuns em pacientes com infarto do miocárdio tipo 2.

29 Mar, 2022 | 15:15h

Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study – Circulation

Comentário: AHA News: Undiagnosed Heart Disease May Be Common in People With Heart Attacks Not Caused by Clots – HealthDay

 

Comentário no Twitter

#OriginalResearch: #DEMAND_MI 1st prospective study to undertake systematic cardiac imaging in patients with type 2 MI. Results show high prevalence of LV dysfunction & CAD @damini_dey @imagingmedsci @marcdweck @jdinaus @andabularga @RyanWereski @chapdoc1 https://t.co/dygODQ92vs pic.twitter.com/ny3Fsyx7wH

— Circulation (@CircAHA) March 28, 2022

 

---

Miocardite e pericardite após vacinação contra COVID-19: diretriz para profissionais da saúde.

29 Mar, 2022 | 15:13h

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals – UK Health Security Agency

Conteúdos relacionados:

Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

---

Metanálise de estudos randomizados | Agonistas receptores de GLP1 aumentam o risco de doenças de vias biliares e vesícula biliar (RR 1,37; IC 95%, 1,23-1,52).

29 Mar, 2022 | 15:07h

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials – JAMA Internal Medicine (gratuito por tempo limitado)

Commentary: GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?— Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug – MedPage Today (gratuito por tempo limitado)

---

Estudo transversal randomizado | Efeitos da restrição de sono experimental sobre a ingestão e o gasto de energia e a obesidade visceral.

29 Mar, 2022 | 14:42h

Effects of Experimental Sleep Restriction on Energy Intake, Energy Expenditure, and Visceral Obesity – Journal of the American College of Cardiology (link para o resumo – $ para o texto completo)

Comentário: Lack of sleep increases unhealthy abdominal fat, study finds – Mayo Clinic

Conteúdo relacionado: RCT: Advising overweight patients to increase sleep duration may reduce caloric intake.

---

Revisão | Como melhorar a adesão dos pacientes ao tratamento da hipertensão.

29 Mar, 2022 | 13:46h

How to improve compliance to hypertension treatment – European Society of Cardiology

 

Comentário no Twitter

#NonAdherence is a major factor for suboptimal #BP control. A one-size-fits-all approach is not ideal. A personalised approach is needed to address it. @spoorthy_burli in #CVPracticeJournal https://t.co/mm1Tjd8fPT@HeartOTXHeartMD @iamritu @AnastasiaSMihai @KreutzReinhold pic.twitter.com/Gdd693gfmU

— European Society of Cardiology Journals (@ESC_Journals) March 25, 2022

 

---

Estudo randomizado | Nitroglicerina não evita a oclusão radial após acesso transradial no cateterismo em laboratório.

29 Mar, 2022 | 13:42h

Randomized Clinical Trial on Prevention of Radial Occlusion After Transradial Access Using Nitroglycerin: PATENS Trial – JACC: Cardiovascular Interventions (link para o resumo – $ para o texto completo)

Comentário: Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS – TCTMD

---

M-A | Comparação da efetividade das estatinas sobre o colesterol não HDL em pessoas com diabetes e risco de doença cardiovascular.

25 Mar, 2022 | 16:17h

Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis – The BMJ

Comunicado de imprensa: Best statins for reducing cardiovascular risk in people with diabetes found – University of Manchester

 

Comentário no Twitter

This network meta-analysis indicated that rosuvastatin, at moderate and high intensity doses, and simvastatin and atorvastatin, at high intensity doses, were most effective at moderately reducing levels of non-HDL-C in patients with diabeteshttps://t.co/NwUf4sX5KA

— The BMJ (@bmj_latest) March 24, 2022

 

---